Victrelis (Boceprevir) Capsule


Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 90.0%
Chronic Hepatitis C 7.9%
Product Used For Unknown Indication 2.1%
Rash 12.3%
Rash Pruritic 10.5%
Vomiting 8.8%
White Blood Cell Count Decreased 8.8%
Thrombocytopenia 7.0%
Abdominal Pain Upper 5.3%
Adverse Event 5.3%
Haemoglobin Decreased 5.3%
Product Quality Issue 5.3%
Red Blood Cell Count Decreased 5.3%
Fatigue 3.5%
Nausea 3.5%
Pyrexia 3.5%
Somnolence 3.5%
Weight Increased 3.5%
Abdominal Pain 1.8%
Decreased Appetite 1.8%
Discomfort 1.8%
Dysgeusia 1.8%
Dysphagia 1.8%
Secondary
Hepatitis C 96.9%
Chronic Hepatitis C 1.9%
Hepatitis C Virus Test Positive 1.1%
White Blood Cell Count Decreased 18.9%
Vomiting 13.5%
Weight Decreased 13.5%
Nausea 8.1%
Pyrexia 6.8%
Rash 5.4%
Drug Ineffective 4.1%
Malaise 4.1%
Pruritus 4.1%
Somnolence 4.1%
Visual Acuity Reduced 4.1%
Fatigue 2.7%
Abdominal Pain 1.4%
Adverse Event 1.4%
Alopecia 1.4%
Diarrhoea 1.4%
Dizziness 1.4%
Dysgeusia 1.4%
Hand Dermatitis 1.4%
Headache 1.4%

Drug Data